期刊
EUROPEAN JOURNAL OF OPHTHALMOLOGY
卷 32, 期 4, 页码 NP78-NP81出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1120672121999344
关键词
Neurotrophic keratopathy; confocal microscopy; childhood glaucoma; human recombinant nerve growth factor
A case of neurotrophic keratopathy in a patient with primary congenital glaucoma was effectively treated with human recombinant Nerve Growth Factor eye drops, leading to complete resolution of corneal integrity and improvement in visual acuity.
Purpose: To report a case of neurotrophic keratopathy (NK) in a patient affected by primary congenital glaucoma (PCG) who undergone glaucoma drainage implant surgery. NK was successfully treated with human recombinant Nerve Growth Factor (Cenegermin) eye drops. Case report description: A 46-years-old patient affected by primary congenital glaucoma underwent Ahmed glaucoma valve implantation in the right eye, after several unsuccessful surgeries to control intraocular pressure (IOP) since the age of three. Surgical intervention was performed without complications, and IOP was well-controlled post-operatively. However, 1 month after surgery, he developed NK with stromal ulceration, initially treated with a topical combination of preservative-free artificial tears and antibiotic ointment. As NK did not resolve, a new treatment with Cenegermin 20 mu g/ml eye drops, 6 times daily, was started. Outcome: NK completely resolved after 8 weeks of Cenegermin treatment, with complete restoration of corneal integrity and improvement of corneal sensitivity and transparency. Visual acuity in the operated eye reverted to the pre-operative value. Conclusion: Cenegermin was extremely effective in restoring corneal integrity in this PCG patient with NK.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据